MedPath
NMPA Approval

Glipizide Extended Release Tablets

J20160045

February 22, 2019

Drug Information

格列吡嗪控释片

瑞易宁

片剂

5mg

化学药品

February 22, 2019

Company Information

Applicant Company

235 East 42nd street,New York,NY 10017,USA

Manufacturing Company

Barceloneta,PR 00617,USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格列吡嗪控释片 - NMPA 批准文号 | MedPath